Oragenics, Inc. Share Price & Technical Analysis
OGEN · $0.58 (-4.92%)
Healthcare / Biotechnology
$0.58
-4.92%
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation wh…
Price chart
Seasonality
Jun has 2 positive and 2 negative years (last 5 years shown)
0% return in Jun, -31% avg return in past 3 year Jun month.
-25% return in 2026, -110% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 0% | -25% | 0% | 0% | 0% | – | – | – | – | – | – | -25% |
| 25 | -18% | -6% | -25% | -10% | -37% | -53% | -28% | -17% | 30% | -8% | -25% | -11% | -208% |
| 24 | -62% | -36% | -2% | -28% | 100% | -50% | -2% | 21% | -69% | -18% | 7% | 16% | -124% |
| 23 | 0% | -30% | -29% | -16% | 6% | 11% | 17% | -4% | -18% | 13% | -5% | 57% | 2% |
| 22 | -7% | -12% | -8% | -6% | 0% | 13% | 6% | -11% | -26% | -12% | -9% | -45% | -117% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.81M
P/E ratio
—
52W high
$5.24
52W low
$0.50
Volume
36,713
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Oragenics, Inc. share price today?
- Oragenics, Inc. (OGEN) last traded around $0.58 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does OGEN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for OGEN. Download the app for real-time alerts.
- How can I analyze Oragenics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.